To overcome this immunosuppressive profile, the use of drugs such as tunicamycin A has been proposed to alter the TDEs N-glycosylation profile that leads to an enhanced immunogenicity, dendritic cell activation, and IFN- mediated CD8 + T-cells activation thus delaying tumor recurrence
GLP-1 therapies are transforming the management of obesity, Type 2 diabetes, cardiovascular disease, and metabolic disorders, creating a market expected to exceed hundreds of billions of dollars over the coming decade
Dosage Guidelines and Precautions for Non-Diabetic Use When used for weight management in non-diabetics, semaglutide is dosed according to product indications and medical guidance
Int J Cancer 51(6):851857 Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994) Intake of fat, meat, and fiber in relation to risk of colon cancer in men
As proof-of-concept, we show that alginate-encapsulated engineered cells implanted in C3H/HeJ male mice can translate circadian inputs or clinically licensed MTNR1A agonists into regulated GLP-1 expression as a therapeutic output exclusively secreted during nighttime, highlighting potential as an experimental cell therapy for obesity-dependent type-2 diabetes
